References | CryoSave India

1

“Stem Cells Basics.”Introduction.In Stem Cell Information (Internet). Bethesda, MD: National Institute of Health U.S Department of Human and Health Services, 2015 (cited Wednesday, April 22, 2015) Available at http://stemcells.nih.gov/info/basics/pages/basics1.aspx

2

“Media Fact Sheet: 1 Million Blood Stem Cell Transplants Worldwide ( internet.” National Marrow Donor Program and Be The Match . Web Accessed Available http://www.wbmt.org/fileadmin/pdf/01_General/One_Million_Transplants_Fact_Sheet_FINAL.pdf

3

Moise, K.J. Jr., Umbilical cord stem cells.” ObsetGynecol 2005. 106 (6): 1393- 1407.

4

“Bone marrow Transplant and Peripheral Blood Transplant”. (Internet) National Cancer Institute at National Institutes of Health. Web Accessed 28-11-2013. http://www.cancer.gov/cancertopics/factsheet/Therapy/bone-marrow-transplant

5

Ven, C. van de., et al. “The potential of umbilical cord blood multipotent stem cells for non-hematopoietic tissue and cell regeneration.” Exp. Hematol. 2007. 35: 1753- 1765.

6

Smith, A.R., et al. “Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.” Br. J. Haematol.2009 147: 246-261.

7

Madrigal, J. A., et al. “Does cord blood transplantation results in lower graft-versus-host disease? It takes more than two to tango.” Human Immunology 1997 56: 1-5. Print.

8

Berz, D., et al. Cryopreservation of hematopoietic stem cells.” Am J Hematol. 2007 82 (6) : 463-472.

9

Gluckman, E., et al. “Hematopoietic reconstitution in a patient with Fanconi’s anemia by umbilical cord blood from an HLA-identical sibling.” N Engl J Med 1989 321.17: 1174-8.

10

Ballen, K. K., et al. “Umbilical cord blood transplantation: the first 25 years and beyond.” Blood 2013 122 4: 491-498.

11

Nietfeld, J. J., et al. Lifetime probabilities of haematopoietic transplantation in the US.Biol Blood Marrow Transplant 2008 14.3 : 316-322.

12

Parents Guide to Cord Blood Foundation. “Diseases Treated.”(Internet) Web Accessed 31-03-2015. http://parentsguidecordblood.org/diseases.php

13

Clinical Trials. (Internet) Last Updadted Web Accessed 01-06-2014. Available https://www.clinicaltrials.gov/

14

Kurtzberg, J., et al. “Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.”N Engl J Med 1996 335 3: 157-166.

15

Tse, W., et al. “Umbilical Cord Blood Transplantation: A New Alternatively Option.” Hematology 2005: 377- 383.

16

Rubinstein, P., “Why cord blood?” Hum Immunol. 2006 67 6: 398-404.

17

Chan, C. C., et al. “Development of Stem Cell Therapy for Medical Uses.” Therapeutic Delivery Solutions 2014 Chapter 9: 239-268. ISBN:978-1-118-1126-0

18

Rocha, V., et al. “Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.” Br. J. Haematol. 2009 147: 261-274.

19

McKenna, D.H., et al. Umbilical Cord blood. AABB Technical Manual, Chapter 31 Pages 823-847.

20

Lapierre, V., et al. Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyl ethyl starch sedimentation) for routine cord blood banking: a comparative study.” Cytotherapy 9 (5) (2007): 514.

21

Lindenmair, A., et al., “Mesenchymal Stem or Stromal Cells from Amnion and Umbilical Cord Tissue and Their Potential for Clinical Applications.” Cells 2012 1: 1061-1088.

22

Harris, D.T., Cord blood stem cells: a review of potential neurological applications.” Stem Cell Rev 2008 4 : 269- 274.

23

Taghizadeh, R.R., “Perinatal Mesenchymal Stem Cell Banking for Umbilical Cord Blood Transplantations and Regenerative Medicine.” Wiley-Blackwell Publishing Perinatal Stem Cells 2 (2013): 53-69.

24

²⁴ Murphy, M.B., et al. “Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.” Experimental & Molecular Medicine 2013 45: e54. Online. Web accessed 18-06-2014.http://www.nature.com/emm/journal/v45/n11/full/emm201394a.html

25

Parikh, M.P., et al. “Hematopoietic stem cell transplantation in India” 50 Years of Cancer Control in India: 136- 49. Web Accessed 14-07-2014. Available at http://www.mohfw.nic.in/WriteReadData/l892s/Hematopoietic%20Stem%20Cell%20Transplantation%20In%20India.pdf

26

“Treatable Conditions” Stem Cell Therapies. Web accessed 28-07-2014.http://www.stemcelltherapies.org/treatable_conditions.html

27

“Learning About Your Disease” Be The Match. Web accessed 28-07-2014. http://marrow.org/For-Patients-and-Families/Learning-about-your-disease/

28

28Pittenger, M.F., et al. “Mesenchymal stem cells and their potential as cardiac therapeutics.” Circ Res 95 (2004): 9-20. Print.

29

29Ichim, T.E., et al. “Mesenchymal stem cells as anti-inflammatories: Implication for treatment of Duchenne muscular dystrophy.” Cellular Immunology 2010 260: 75-82.

30

30What are the unique“ properties of all stem cells ? In Stem Cell Information( Internet). Bethesda, MD: National Institutes of Health, U.S Department of Health and Human Services, 2015(cited Wednesday, April 22,2015) Available at. http://stemcells.nih.gov/info/basics/pages/basics2.aspx

31

31Choo, S. Y., “”The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications.” Yonsei Med J 48 (1) (2007): 11-23.

32

Regenerative Medicine. NIH Fact Sheets. (Internet)Bethesda, MD: National Institute of Health U.S Department of Human and Health Services (cited Tuesday June 21, 2016) Available at: https://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=62

33

33Parikh, M.P., et al. “Hematopoietic stem cell transplantation in India” 50 Years of Cancer Control in India: 136- 49. Web Accessed 14-07-2014. Available at http://www.mohfw.nic.in/WriteReadData/l892s/Hematopoietic%20Stem%20Cell%20Transplantation%20In%20India.pdf

34

Gluckman, E., et al. “Outcome of cord-blood transplantation from related and unrelated donors.” N Engl J Med 1997 337 (6): 373- 381. Print.

35

McKenna, D.H., et al. Umbilical Cord blood. AABB Technical Manual, Chapter 31 Pages 823-847.

36

Lapierre, V., et al. Cord blood volume reduction using an automated system  (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyl ethyl starch sedimentation) for routine cord blood banking: a comparative study.” Cytotherapy 9 (5) (2007): 514.

37

Friedman, R., et al. “Umbilical cord mesenchymal stem cells: Adjuvants for human cell transplantation.” Biology of Blood and Marrow Transplantation 13 (2007): 1477- 86.

38

Lennard, A.L., et al. “Science, medicine and the future: Stem Cell Transplantation.” BMJ 321(7258) (2000): 433-437. Print.

39

Johnson, J.D., et al. “How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?” Transfusion 51 (2011): 1143- 1149. Print.

40

Broxmeyer, H.E., et al. “Hematopoietic stem/ progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21-to 23.5- year cryopreserved cord blood.” Blood 117 (2011): 4773-4777. Print.
Get in Touch

We are glad that you preferred to contact us. Please fill our short form and one of our friendly team members will contact you back.

Name*

Email*

Mobile*

City*

Nature of Query

Message

X
CONTACT US